Wall Street quiet as solar eclipse takes center stage >>> READ MORE

XBI

SPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin’ on Biotech Stocks

Buyers are dominating in biotech stocks. Embrace the relative strength with this XBI play. High-probability profits await. More 

Biotech SPDR (XBI): Opportunity Lurks Amid the Biotech Swoon

The biotech stock swoon is a blip on the radar, nothing more. Fade the fear by selling juiced up XBI put options. More 

The 10 Best ETFs on the Planet

The best ETFs on the planet will outperform because of powerful generational megatrends, or just because they're built to withstand anything. More 

SPDR S&P Biotech (ETF) (XBI): Embrace the Biotech Bulls’ Return

Strength is returning anew to biotech stocks. Embrace the sector with a play on XBI to capitalize on further gains. More 

Gilead Sciences, Inc.: A Breakdown Looms for GILD Stock

Gilead Sciences is sitting out the biotech stock rally. In fact, an ugly breakdown looms for the ailing drug stock. Buy GILD stock puts. More 

3 High-Growth ETFs That Are Just Waiting to Explode

Investors have lost their nerve for now, but these growth plays are going to be prime buying grounds the second Wall Street perks up. More 

Biotech Bloodbath: Ditch XBI, IBB for Now

Biotech ETFs IBB and XBI are in a hurt locker right now. Even if you're bullish on biotechs for the long-term, consider a hedge play or two for now. More